Question follow-through · 32415

Mental Health Services: Children

To ask the Secretary of State for Health and Social Care, what the average time was between (a) referral and (b) first contact for mental health services for people aged 17 years and under in (a) Salford and (b) Wigan in each of the last five years.

answeredDepartment of Health and Social Care

About this written question

A written question asks a government minister for information in writing. Parliament publishes the question and any answer.

Answering body
Department of Health and Social Care
Tabled
21 Feb 2025
Target answer date
4 Mar 2025
Answer
4 Mar 2025 · 11 calendar days after tabling

Elapsed calendar days describe the record timeline, not whether Parliament considers an answer on time.

More questions by this MP on Health and care

Shared topic keywords suggest a connection; they do not establish a follow-up.

Votes on this topic

These Commons divisions share a topic label. The question did not necessarily lead to a vote.

Recorded timeline

  1. 21 Feb 2025

    Question tabled

    To ask the Secretary of State for Health and Social Care, what the average time was between (a) referral and (b) first contact for mental health services for people aged 17 years and under in (a) Salford and (b) Wigan in each of the last five years.

  2. 4 Mar 2025

    Target answer date

    Date supplied by the official written-questions record.

  3. 4 Mar 2025

    Answer published

    The following table shows the median waiting time in days between a referral start date and first contact, within the three-month rolling reporting period, for referrals for children and young people aged under 18 years old who are supported through Natio...

Open official record

Official data retrieved 28 Sept 2026.

Later records

Possible follow-up questions

Strong links require the same MP, department and exact heading. Other same-department questions are shown as unreviewed candidates, not as confirmed follow-ups. No debate link is asserted unless a stable source relationship exists.

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Mental Health Services: Greater Manchester

24 Feb 2025 · To ask the Secretary of State for Health and Social Care, how many referrals have been accepted by Child and Adolescent Mental Health Services in (a) Salford and (b) Wigan in each of the last five years.

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Mental Health Services: Children and Young People

25 Feb 2025 · To ask the Secretary of State for Health and Social Care, how many people have been waiting over six months to access CAMHS support in (a) Salford and (b) Wigan.

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Dental Services: Worsley and Eccles

6 Mar 2025 · To ask the Secretary of State for Health and Social Care, what steps his Department is taking to increase access to NHS dentistry in Worsley and Eccles constituency.

Unreviewed candidateSame MP and department; topic relationship is unreviewed

ADHD: Patient Choice Schemes

17 Mar 2025 · To ask the Secretary of State for Health and Social Care, whether he has made an assessment of the potential impact of the abolition of NHS England on the (a) consultation on NHS Right to Choose ADHD changes and (b) use of feedback from that consultation.

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Pancreatic Enzyme Replacement Therapy: Supply Chains

3 Jul 2025 · To ask the Secretary of State for Health and Social Care, whether his Department has conducted a 360-degree supply and demand forecast for pancreatic enzyme replacement therapy to assess the long-term needs for patients.

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Pancreatic Enzyme Replacement Therapy: Supply Chains

3 Jul 2025 · To ask the Secretary of State for Health and Social Care, what steps he is taking to ensure that lessons learned from the COVID-19 Vaccine Taskforce will inform its approach to managing the shortages of pancreatic enzyme replacement therapy (PERT).

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Health Services: Apprentices

14 Jul 2025 · To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the potential impact of the planned changes to funding for Level 7 apprenticeships for Specialist Community Public Health Nurses after January 2026; and w

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Nurses: Schools

14 Jul 2025 · To ask the Secretary of State for Health and Social Care, what plans his Department has to increase the recruitment and retention of school nurses; how much funding was allocated for school nursing services in the (a) 2024-25 and (b) 2025-26 financial yea

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Midwives and Nurses: Recruitment

28 Jan 2026 · To ask the Secretary of State for Health and Social Care, how the eligibility criteria for the Graduate Guarantee scheme for newly qualified nurses and midwives in England was determined.

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Midwives and Nurses: Recruitment

28 Jan 2026 · To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the potential merits of extending the Graduate Guarantee scheme for newly qualified nurses and midwives in England to include graduates who qualified prio

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Idiopathic Pulmonary Fibrosis: Drugs

3 Feb 2026 · To ask the Secretary of State for Health and Social Care, whether his Department has an estimate of the earliest possible date Jascayd (nerandomilast) could be available to idiopathic pulmonary fibrosis patients.

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Idiopathic Pulmonary Fibrosis: Drugs

3 Feb 2026 · To ask the Secretary of State for Health and Social Care, whether his Department has considered the implications of the UK-US Economic Prosperity Deal for the potential approval of Jascayd (nerandomilast).